RS52492B - MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind - Google Patents

MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind

Info

Publication number
RS52492B
RS52492B RS20120412A RSP20120412A RS52492B RS 52492 B RS52492 B RS 52492B RS 20120412 A RS20120412 A RS 20120412A RS P20120412 A RSP20120412 A RS P20120412A RS 52492 B RS52492 B RS 52492B
Authority
RS
Serbia
Prior art keywords
epitope
species
cross
binding
specific bispecific
Prior art date
Application number
RS20120412A
Other languages
English (en)
Serbian (sr)
Inventor
Matthias Klinger
Tobias Raum
Doris Rau
Roman Kischel
Ralf LUTTERBĂśSE
Patrick Hoffmann
Peter Kufer
Susanne Mangold
Original Assignee
Amgen Research (Munich) Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Research (Munich) Gmbh filed Critical Amgen Research (Munich) Gmbh
Priority claimed from PCT/EP2008/002663 external-priority patent/WO2008119566A2/en
Publication of RS52492B publication Critical patent/RS52492B/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RS20120412A 2007-04-03 2008-04-03 MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind RS52492B (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
EP07006990 2007-04-03
EP07006988 2007-04-03
US91366807P 2007-04-24 2007-04-24
EP07020646 2007-10-22
EP07020640 2007-10-22
EP07020641 2007-10-22
EP08004741 2008-03-13
PCT/EP2008/002663 WO2008119566A2 (en) 2007-04-03 2008-04-03 Cross-species-specific bispecific binders

Publications (1)

Publication Number Publication Date
RS52492B true RS52492B (en) 2013-02-28

Family

ID=42582614

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20120412A RS52492B (en) 2007-04-03 2008-04-03 MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind

Country Status (8)

Country Link
JP (1) JP2010524435A (pt)
DK (1) DK2155788T3 (pt)
ES (1) ES2390243T3 (pt)
NZ (1) NZ580746A (pt)
PT (1) PT2155788E (pt)
RS (1) RS52492B (pt)
RU (1) RU2535992C2 (pt)
SI (1) SI2155788T1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101626988B1 (ko) * 2007-04-03 2016-06-02 암젠 리서치 (뮌헨) 게엠베하 종간 특이적 이중특이적인 결합제들
HUE040467T2 (hu) * 2007-04-03 2019-03-28 Amgen Res Munich Gmbh Keresztfaj-specifikus kötõdomén
WO2012066058A1 (en) * 2010-11-16 2012-05-24 Boehringer Ingelheim International Gmbh Agents and methods for treating diseases that correlate with bcma expression
CN107903325B (zh) * 2011-05-16 2021-10-29 埃泰美德(香港)有限公司 多特异性fab融合蛋白及其使用方法
NZ703939A (en) * 2011-05-21 2016-01-29 Macrogenics Inc Cd3-binding molecules capable of binding to human and non-human cd3
RS60453B1 (sr) 2013-12-17 2020-07-31 Genentech Inc Anti-cd3 antitela i postupci upotrebe
WO2015181098A1 (en) * 2014-05-28 2015-12-03 F. Hoffmann-La Roche Ag Antibodies binding to human and cynomolgus cd3 epsilon
EP3172235A2 (en) * 2014-07-25 2017-05-31 Cytomx Therapeutics Inc. Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
ES2980787T3 (es) * 2014-07-31 2024-10-03 Amgen Res Munich Gmbh Constructo de anticuerpo de cadena sencilla biespecífico con distribución tisular potenciada
EP3778640A1 (en) * 2015-05-01 2021-02-17 Genentech, Inc. Masked anti-cd3 antibodies and methods of use
CA3017776A1 (en) 2016-03-15 2017-09-21 Generon (Shanghai) Corporation Ltd. Multispecific fab fusion proteins and use thereof
TWI791471B (zh) 2016-11-15 2023-02-11 美商建南德克公司 用於用抗ｃｄ２０/抗ｃｄ３雙特異性抗體進行治療之給藥
US10426424B2 (en) 2017-11-21 2019-10-01 General Electric Company System and method for generating and performing imaging protocol simulations
AR115360A1 (es) 2018-02-08 2021-01-13 Genentech Inc Moléculas de unión al antígeno y métodos de uso
US20230067182A1 (en) * 2019-11-29 2023-03-02 Boe Technology Group Co., Ltd. Data Processing Device and Method, and Computer Readable Storage Medium
TW202128767A (zh) 2019-12-13 2021-08-01 美商建南德克公司 抗ly6g6d抗體及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD272473B3 (de) * 1988-06-13 1993-01-21 Univ Leipzig Verfahren zur herstellung monoklonaler antikoerper gegen die epsilon-kettedes cd 3-antigens humaner t-lymphozyten
US7235641B2 (en) * 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies

Also Published As

Publication number Publication date
SI2155788T1 (sl) 2012-11-30
DK2155788T3 (da) 2012-10-08
RU2009136913A (ru) 2011-06-20
RU2535992C2 (ru) 2014-12-20
PT2155788E (pt) 2012-09-25
ES2390243T3 (es) 2012-11-07
NZ580746A (en) 2012-05-25
JP2010524435A (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
RS52492B (en) MOLECULES WHICH INTERSPECIALLY SPECIFICALLY BISPECIFICALLY Bind
RS54900B1 (sr) Interspecijski specifično psmaxcd3 bispecifično jednolančano antitelo
RS53008B (en) INTERSPECTION SPECIFIC CD3-EPSILON BINDING DOMAIN
NZ602209A (en) Cross-species-specific psmaxcd3 bispecific single chain antibody
AR109355A2 (es) Moléculas de unión al receptor ox40 humano
RS54675B1 (en) MONOVALENT MIXTURES FOR CD28 BINDING AND METHODS OF USE
TW200745164A (en) Gene recombination antibodies composition
RU2019100481A (ru) Биспецифические антитела-ингибиторы контрольных точек
RU2014144143A (ru) Химерные антигенные рецепторы, нацеленные на антиген созревания в-клеток
RS54359B1 (en) ANTI CD37 ANTIBODIES
RS52484B (en) CD40 ANTIBODIES
EA200870555A1 (ru) Слитые белки, их применение и способы их получения
RU2013110875A (ru) БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА, СОДЕРЖАЩИЕ СТАБИЛИЗИРОВАННЫЙ ДИСУЛЬФИДОМ ФРАГМЕНТ Fv
NZ584838A (en) Novel antibodies which bind alpha5beta1 (fibronectin receptor) and uses thereof
CO5261584A1 (es) Anticuerpos para il-1 humana
RS54424B1 (en) HUMAN ANTIBODIES CONCERNING CXCR4 AND THEIR USES
NZ590668A (en) TNF-alpha ANTAGONIST MULTI-TARGET BINDING PROTEINS
RS52775B (en) CD19 OPTIMIZED ANTIBODY
NZ716762A (en) Specific binding proteins and uses thereof
ATE408624T1 (de) Verfahren zur reinigung von fsh
RS54299B1 (en) COMPOSITIONS AND METHODS OF USING THERAPY ANTIBODIES
BRPI0410031A (pt) variantes fc otimizadas e métodos para sua geração
MX2016011934A (es) Inmunoglobulina hibrida conteniendo un enlace no-peptidilico.
WO2005066867A3 (en) Modulators of cell-surface receptors of the ig-class
SG149004A1 (en) Inhibitors of type 2 vascular endothelial growth factor receptors